New Canadian contraceptive is an abortifacient, distributor’s site says

CANADA, June 15, 2009—CANADIAN subscribers of contraceptive pill NorLevo better check the drug’s label—or its distributor’s own website—before they even gulp another dosage.

On their product launch last June 10, Norlevo’s manufacturer HRA Pharma, a European pharmaceutical company stated that “NorLevo® is not an abortive agent. If a woman is already pregnant, NorLevo® will not terminate the pregnancy.”

However, NorLevo’s own website confirms that the drug is indeed an abortifacient. In answering how the drug works, the company explains: “Our current understanding is that several mechanisms could be involved such as impairment of ovulation, or modification of the uterine lining. In any case, emergency contraception takes effect before the implantation of the egg in the uterus.”

The phrase “the modification of the uterine lining” indicates that—as with other “emergency contraception”—the drug makes the womb unaccommodating to a fertilized embryo, ensuring that the newly conceived human life will be unable to implant, and will therefore die.

Gwen Landolt of REAL Women Canada, in an interview with LSN, called the newly approved drug “medically questionable.”

“And the implications are, of course, that women don’t have to worry about … becoming pregnant, because she can just hop over and get her morning after pill, even though it’s highly detrimental to her” she said.

Groups that promote the use of “emergency contraception” have responded to criticisms that such drugs cause early abortions by altering the definition of what constitutes a “pregnancy.”

As Prof. Richard Stith explained in a 2006 LSN column: “According to the new definitions, ‘conception’ and ‘pregnancy’ begin at implantation rather than at fertilization, and ‘abortion’ means the termination of a post-implantation ‘pregnancy.’ The drug makers can claim, rightly, that their statements are true under these new definitions.”

Bayer Inc. will market and distribute the drug locally. NorLevo will be available in Canadian pharmacies without a doctor’s prescription.

Credits:
Cited from an original article by Patrick B. Craine and John Jalsevac from lifesitenews.com dated 06/15/09